# Efficacy and Safety Evaluation of Vi-sealer

> **NCT05629611** · NA · RECRUITING · sponsor: **Hyun Park** · enrollment: 280 (estimated)

## Conditions studied

- Benign Gynecologic Neoplasm

## Interventions

- **DEVICE:** Vi-Sealer
- **DEVICE:** Ligasure
- **DEVICE:** Other AHD

## Key facts

- **NCT ID:** NCT05629611
- **Lead sponsor:** Hyun Park
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-20
- **Primary completion:** 2024-12
- **Final completion:** 2025-10-31
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05629611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05629611, "Efficacy and Safety Evaluation of Vi-sealer". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05629611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*